Immune therapy to improve recovery after traumatic brain injury
Novel immune therapy to promote functional recovery after traumatic brain injury
This project is testing an immune-based treatment aimed at helping adults regain brain function after a traumatic brain injury.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11212770 on NIH RePORTER |
What this research studies
Researchers are developing an immune therapy that uses regulatory T cells to encourage brain-supporting immune cells (microglia and macrophages) to shift from harmful inflammation toward repair. In lab and preclinical models, they will study how these immune changes help brain cells such as oligodendrocytes mature and support tissue recovery. The work focuses on the biology behind long-term damage after TBI to find targets that could be turned into new treatments. If the approach translates, it could guide future treatments for veterans and civilians with moderate-to-severe TBI.
Who could benefit from this research
Good fit: Adults who have experienced a moderate-to-severe traumatic brain injury and who are receiving care at VA or affiliated research centers would be the likely candidates if human work is offered.
Not a fit: People with mild TBI, non-traumatic brain injuries, or medical conditions that prevent immune-based therapies may not benefit from this specific approach.
Why it matters
Potential benefit: If successful, this approach could reduce damaging inflammation and promote brain repair, improving long-term function after TBI.
How similar studies have performed: Related preclinical work, including studies of regulatory T cells in stroke models, has shown neuroprotective effects, but applying this approach to TBI is relatively new and still experimental.
Where this research is happening
Pittsburgh, United States
- Veterans Health Administration — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hu, Xiaoming — Veterans Health Administration
- Study coordinator: Hu, Xiaoming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.